Merck’s immunotherapy, chemo mix shows extended lung cancer gains – Reuters
|
Merck's immunotherapy, chemo mix shows extended lung cancer gains
Reuters MADRID (Reuters) – Giving Merck & Co's immunotherapy drug Keytruda in combination with chemotherapy for previously untreated advanced lung cancer appears to provide durable benefits, according to an update of a closely watched clinical trial. |
